Abstract
eHealth studies typically suffer from high attrition rates. Objective To investigate type 2 diabetes and heart disease patients’ adherence to a self-management intervention that combined health coaching and telemonitoring. Methods Renewing Health Finland was a 12-month randomized controlled trial to improve quality of life (QoL) and/or HbA1c of 595 patients with chronic conditions. The intervention consisted of (1) weekly measurement of health parameters (2) health coaching every 4–6 weeks. Adherence to telemonitoring was defined as the percentage of weeks with at least one reported health measurement. Adherence to coaching was defined as the number of received calls. Results The median percentage of monitored weeks was 65 % without time-dependent attrition. 66 % of participants received 7–11 calls that corresponds to the predefined coaching schedule. Adherence did not correlate with QoL or HbA1c. Discussion Our results indicate that the intervention in the Renewing Health Finland trial was delivered almost with planned intensity.
Original language | English |
---|---|
Title of host publication | Building Sustainable Health Ecosystems |
Subtitle of host publication | WIS 2016 |
Publisher | Springer |
Pages | 57-66 |
ISBN (Electronic) | 978-3-319-44672-1 |
ISBN (Print) | 978-3-319-44671-4 |
DOIs | |
Publication status | Published - 3 Sept 2016 |
MoE publication type | A4 Article in a conference publication |
Event | 6th International Conference on Well-Being in the Information Society, WIS 2016: Building Sustainable Health Ecosystems - Tampere, Finland Duration: 16 Sept 2016 → 18 Sept 2016 Conference number: 6 |
Publication series
Series | Communications in Computer and Information Science |
---|---|
Volume | 636 |
Conference
Conference | 6th International Conference on Well-Being in the Information Society, WIS 2016 |
---|---|
Abbreviated title | WIS 2016 |
Country/Territory | Finland |
City | Tampere |
Period | 16/09/16 → 18/09/16 |
Keywords
- adherence
- telemonitoring
- health coaching
- QoL
- HbA1c
- type 2 diabetes
- heart disease